Clinical trial
ATV/Ritonavir Nevirapine Interaction (USPAC)
NCT00162149 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00162149 |
|---|---|
| Title | ATV/Ritonavir Nevirapine Interaction (USPAC) |
| Official title | Open-Label, Multiple-Dose, Drug Interaction Study to Assess the Effect of Nevirapine on the Pharmacokinetics of Atazanavir in HIV-Infected Individuals |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Nevirapine, Nevirapine + Atazanavir/Ritonavir, Atazanavir + Ritonavir |
| Enrollment | 46 |
| Start date | Oct 1, 2005 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Sep 13, 2005 |
| Last update posted | Apr 8, 2011 |
| Countries | United Kingdom, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: